1-43 Drug Metabolism II Flashcards
Acetominophen: drug metabolism
- “phase 1” unnecessary because OH group “pre-lubbed” on acetominophen
- low dose: phase 2 either GLUCURONIDATION or SULFATION, either way nontoxic intermediate in excreted in urine
-
high dose: phase 1ish CYP2E1 and CP3A4 add hydroxyl group anyways, molecule unhappy and rearragnes to form NAPQI (evil electrophile, toxic intermediate)
- luckily: glutathione can bind NAPQI and saves cell from destruction
-
unluckily: if glutathione depleted and cannot save, NAPQI binds to nucleophillic cell macromolecules in liver cells and causes liver cell death
- sadly: glutathione does not cross cell membranes well so we cannot use as antiodote
- happily: N-acetylcysteine (NAC) conjugates directly with NAPQI and can replace glutathione stores, also antiooxidant properties
Polymorphisms in CYP dependent oxidations (ALL)
- CYP3A4: bell shaped curve in population, theremore not known to contirbute significanlty to individual variability
-
CYP2D6: most common polymorphisms
-
Poor metabolizers: inheritance of 2 mutant CYP2D6 alleles
- 9% caucasions
- 2% AA
- 5% hispanic
- Asian <1%
-
Rapid metabolizers: duplication or amplyfication of CYP2D6 genes, excessibe expression of enzyme high metabolic capacity
- North Africans: 30%
- Many drugs used to treat CNS disorders use CYP2D6!
- Ex: metoprolol: B1s blocker to treat elevated heart rate/HTN/arrhythmia poor metabolzier require lower dose, rapid metabolizer require higher dose
- Ex: codeine (weak agonist): converted by CYP2D6 to morhpine (full agonist), rapid metabolizers have adverse effects to codeine because rapidly converted to morphine causing sedation / respiratory depression therefore use lower doses in rapid meta, do not use in poor metabolizers
-
Poor metabolizers: inheritance of 2 mutant CYP2D6 alleles
-
CYP2C19: 15-25% asians poor metabolizers
-
Diazepam: long-acting benzodiazepine, requires CYP2C19 to funcitonalize the molecule via N-dealkylation then via hydrozylation for the glucuronideation inactivation necessary for excretion
- half life of diazepam can be >4x longer than normal
-
Omeprazole: proton pump inhibiors, tx excessive acid secretion (ulcers), irreversibly blocks pp
- therefore reduce doses for poor metabolizers population
-
Diazepam: long-acting benzodiazepine, requires CYP2C19 to funcitonalize the molecule via N-dealkylation then via hydrozylation for the glucuronideation inactivation necessary for excretion
-
CYP2C9: 10-35% caucasians poor metabolizers
-
Warfarin: increases clotting time (anticoag) to prevent stroke, blocks carboxylation of coagulation factors, side effect increased bleeding, TI=1
- changes number od days required for stable anticoagulation because slowly metabolizing
- Ibuprofen (NSAID): pain relief antiinflam, inhbits both housekeeping (COX-1) (maintains normal kidney and GI fxn with prostaglnadin synthesis)and painful (COX-2) cyclooxygenases (makes the painful prostaglandins)
-
Celecoxib (NSAID): pain relief antiinflam, used to treat post op pain, selectively inhibits the cyclooxygenase (COX-2) responsible for pain
- poor metabolizers require lower doses
-
Warfarin: increases clotting time (anticoag) to prevent stroke, blocks carboxylation of coagulation factors, side effect increased bleeding, TI=1
Polymorphisms in CYP dependent oxidations (CYP3A4)
- CYP3A4: bell shaped curve in population, theremore not known to contirbute significanlty to individual variability
Polymorphisms in CYP dependent oxidations (CYP2D6)
-
CYP2D6: most common polymorphisms
-
Poor metabolizers: inheritance of 2 mutant CYP2D6 alleles
- 9% caucasions
- 2% AA
- 5% hispanic
- Asian <1%
-
Rapid metabolizers: duplication or amplyfication of CYP2D6 genes, excessibe expression of enzyme high metabolic capacity
- North Africans: 30%
- Many drugs used to treat CNS disorders use CYP2D6!
- Ex: metoprolol: B1s blocker to treat elevated heart rate/HTN/arrhythmia poor metabolzier require lower dose, rapid metabolizer require higher dose
- Ex: codeine (weak agonist): converted by CYP2D6 to morhpine (full agonist), rapid metabolizers have adverse effects to codeine because rapidly converted to morphine causing sedation / respiratory depression therefore use lower doses in rapid meta, do not use in poor metabolizers
-
Poor metabolizers: inheritance of 2 mutant CYP2D6 alleles
Polymorphisms in CYP dependent oxidations (CYP2C19)
-
CYP2C19: 15-25% asians poor metabolizers
-
Diazepam: long-acting benzodiazepine, requires CYP2C19 to funcitonalize the molecule via N-dealkylation then via hydrozylation for the glucuronideation inactivation necessary for excretion
- half life of diazepam can be >4x longer than normal
-
Omeprazole: proton pump inhibiors, tx excessive acid secretion (ulcers), irreversibly blocks pp
- therefore reduce doses for poor metabolizers population
-
Clopidogrel: antiplatelet agent, prodrug, active metabolite requires activation by CYP2C19
- therefore poor metabolizers are not properly anticoagulated post surgery and have higher risk for stroke post stenting
-
Diazepam: long-acting benzodiazepine, requires CYP2C19 to funcitonalize the molecule via N-dealkylation then via hydrozylation for the glucuronideation inactivation necessary for excretion
Polymorphisms in CYP dependent oxidations (CYP2C9)
-
CYP2C9: 10-35% caucasians poor metabolizers
-
Warfarin: increases clotting time (anticoag) to prevent stroke, blocks carboxylation of coagulation factors, side effect increased bleeding, TI=1
- changes number od days required for stable anticoagulation because slowly metabolizing
- Ibuprofen (NSAID): pain relief antiinflam, inhbits both housekeeping (COX-1) (maintains normal kidney and GI fxn with prostaglnadin synthesis)and painful (COX-2) cyclooxygenases (makes the painful prostaglandins)
-
Celecoxib (NSAID): pain relief antiinflam, used to treat post op pain, selectively inhibits the cyclooxygenase (COX-2) responsible for pain
- poor metabolizers require lower doses
-
Warfarin: increases clotting time (anticoag) to prevent stroke, blocks carboxylation of coagulation factors, side effect increased bleeding, TI=1
Polymorphism in CYP independent OXIDATIONs- alcohol metabolism
Ethanol via ALCOHOL DEHYDROGENASE -> Acetaldehyde via ALDEHYDE DEHYDROGENASE -> Acetate
- build up of acetaldehyde causes unpleasant alchol symptoms
- Alcohol dehydrogenase reaction is enhanced: accumulation of acetaldehyde and second step of rxn cannot keep up, 90% chinese population 5-20% caucasians
- Aldehyde dehydrogenase is deficient: accumulation of acetaldehyde in 30-50% of Chinese/Japanses
Polymorphisms in Hydrolysis
- Plasma cholinesterase responsible for the degredation of succinylcholine is variable
- if the amount of activity is reduced then could over-intibate a patient requiring ventilation and NM paralysis
Genetic variations in N-acetyltransferase (NAT)
- biomodal distribution, fast and slow
-
slow acetylators: have LESS NAT (not due to abnormal enzyme)
- phenotype: 50% blacks/whites, associated with higher incidence of drug induced bladder cancers, toxic effects of isoniazid and other NAT substrates
- Isoniazid (antimicrobial): toxic effects of high doses because cannot inactivate quickly
- phenotype: 50% blacks/whites, associated with higher incidence of drug induced bladder cancers, toxic effects of isoniazid and other NAT substrates
Genetic variations in Glutathione (phase II metabolism rxns)
-
GST and glutathion-null genotypes
- increased risk of cancers, CML
- Mu genotype: 50% caucasians, absence of GST activity linked to leukemia, lung, colon, bladder cancers
-
Theta genotype: 60% chinese koreans: absence of GST activity linked to increased risk of leukemia and prostate cancers
- toxicity of cancer chemotherapy drugs because they cannot be cleared by glutathione conjugation
Why the broad substrate spectrum of CYP3A4?
- Large active site, can accomidate many diff drugs
- shapes dont matter for CYP3A4
CYP1A2
- metabolizes methyl xanthines
- caffeine
- theophylline
CYP2E1
- toxicity producing in acetaminophen metabolism, makes NAPQI
- may be induced by ethanol or isoniazid
- low doses of ethanol use the dehydrogenases for metabolism
- higher doses use and INDUCE CYP2E1
Ethanol and acetaminophen toxicity
- Ethanol induces CYP2E1 to create toxic intermediate NAPQI
- Ethanol reduces glutathione conentration and prevents it from rescuing NAPQI
Pollutants that can affect CYPs
- CYP1A: induced by environmental pollutants (smoking, factories, also by charcoal foods and cruciferous vegetables)
-
Benzoapyrines: worse cultrit to produce cancers from enviornemnt pollutants
- found in coal tar, cig smoke, charbroiled foods
CYP1A induction causes benzoapyrines to form epoxides
- benxoapyrene traverses PM and binds AHR (aryhydrocarbon receptor, ligand activated TF), AHR traverses to nucleus and initiates CYP1A gene transcription